Clinical Trial Update: Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Clinical trial update for IMU-838 evaluating efficacy, safety, and tolerability in progressive multiple sclerosis; Phase 2 study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• IMU-838 (IMU-838)

Snippet

Sponsor: Immunic AG | Conditions: Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING